A rescue inhaler that pairs a bronchodilator with an anti-inflammatory steroid just changed the conversation about “mild” asthma.
In a recent study, Airsupra reduced the risk of a severe asthma attack by 47 percent versus albuterol alone and cut yearly oral steroid exposure.
Read more
